DESIDERI, ISACCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.643
AS - Asia 8.017
EU - Europa 7.296
SA - Sud America 927
AF - Africa 193
OC - Oceania 116
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 29.194
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.443
RU - Federazione Russa 3.254
SG - Singapore 2.360
CN - Cina 2.314
IT - Italia 1.086
HK - Hong Kong 1.036
KR - Corea 741
BR - Brasile 724
VN - Vietnam 638
IE - Irlanda 626
PL - Polonia 515
SE - Svezia 388
FR - Francia 386
DE - Germania 311
IN - India 265
FI - Finlandia 230
GB - Regno Unito 195
JO - Giordania 152
AU - Australia 113
CA - Canada 103
ID - Indonesia 102
BD - Bangladesh 99
AR - Argentina 76
ES - Italia 57
NL - Olanda 55
MX - Messico 52
JP - Giappone 50
IQ - Iraq 44
CH - Svizzera 39
NG - Nigeria 36
EC - Ecuador 34
ZA - Sudafrica 32
TR - Turchia 31
PK - Pakistan 29
VE - Venezuela 26
CI - Costa d'Avorio 25
CZ - Repubblica Ceca 23
BE - Belgio 22
CO - Colombia 22
MA - Marocco 21
UA - Ucraina 20
EG - Egitto 17
UZ - Uzbekistan 16
SA - Arabia Saudita 15
TN - Tunisia 15
LT - Lituania 14
AE - Emirati Arabi Uniti 13
CL - Cile 13
KE - Kenya 13
PH - Filippine 13
AT - Austria 12
BJ - Benin 11
PY - Paraguay 11
BG - Bulgaria 10
PE - Perù 9
CR - Costa Rica 8
IL - Israele 8
UY - Uruguay 8
AZ - Azerbaigian 7
DO - Repubblica Dominicana 7
GR - Grecia 7
IR - Iran 7
KG - Kirghizistan 7
KZ - Kazakistan 7
NP - Nepal 7
TH - Thailandia 7
TT - Trinidad e Tobago 7
BY - Bielorussia 6
DZ - Algeria 6
SC - Seychelles 5
SK - Slovacchia (Repubblica Slovacca) 5
AL - Albania 4
BH - Bahrain 4
DK - Danimarca 4
HN - Honduras 4
LA - Repubblica Popolare Democratica del Laos 4
LB - Libano 4
MM - Myanmar 4
OM - Oman 4
PA - Panama 4
PS - Palestinian Territory 4
RO - Romania 4
BO - Bolivia 3
EE - Estonia 3
GE - Georgia 3
HU - Ungheria 3
JM - Giamaica 3
KH - Cambogia 3
LK - Sri Lanka 3
LV - Lettonia 3
MY - Malesia 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SI - Slovenia 3
AO - Angola 2
CG - Congo 2
ET - Etiopia 2
HR - Croazia 2
KW - Kuwait 2
Totale 29.159
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.678
Ashburn 1.820
Singapore 1.776
Hong Kong 894
Fairfield 886
Seoul 740
Hefei 733
Dublin 623
San Jose 609
Chandler 575
Warsaw 500
Seattle 412
Woodbridge 401
Cambridge 363
Houston 345
Beijing 320
Wilmington 298
Los Angeles 228
Ho Chi Minh City 221
Moscow 217
Munich 189
Florence 180
Buffalo 178
Ann Arbor 170
New York 165
The Dalles 160
Lawrence 159
Lauterbourg 158
Altamura 147
Paris 136
Hanoi 129
Council Bluffs 122
Dearborn 118
Princeton 115
Kent 114
Helsinki 113
Shanghai 106
Melbourne 104
Mumbai 96
Boston 84
Dallas 77
Milan 76
São Paulo 66
London 65
Jakarta 61
Rome 60
San Diego 58
Turku 58
Medford 54
Bengaluru 53
Clifton 53
Frankfurt am Main 53
West Jordan 42
Orem 40
Tokyo 40
Boardman 34
Lappeenranta 34
Guangzhou 33
Abuja 31
Bern 30
Chennai 30
Chicago 30
Brooklyn 29
Stockholm 29
Toronto 28
Montreal 27
Pune 27
Abidjan 25
Da Nang 25
Redondo Beach 25
Atlanta 23
Belo Horizonte 23
Brussels 22
Rio de Janeiro 22
Dong Ket 21
Phoenix 21
San Francisco 21
Haiphong 20
Johannesburg 20
Baghdad 19
Denver 19
Falls Church 18
Barcelona 17
Mexico City 17
Biên Hòa 16
Buenos Aires 16
Naples 16
Porto Alegre 16
Tashkent 16
Brasília 15
Hillsboro 15
Poplar 15
Yubileyny 15
Manchester 14
Quito 14
Bologna 13
Norwalk 13
Tianjin 13
Nanjing 12
Redwood City 12
Totale 19.189
Salva come PNG Salva come JPEG
Nome #
Hypofractionation in prostate cancer: radiobiological basis and clinical appliance. 322
A multiparametric method to assess the MIM deformable image registration algorithm 283
Efficacy and tolerability of cyberknife stereotactic robotic radiotherapy for primary or secondary orbital lesions: A single-center retrospective experience 278
Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial 257
What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis 255
A matched cohort study of radio-chemotherapy versus radiotherapy alone in soft tissue sarcoma patients 239
A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model 238
Accuracy of Orthopantomography for Apical Periodontitis without Endodontic Treatment 237
Is Panoramic Radiography an Accurate Imaging Technique for the Detection of Endodontically Treated Asymptomatic Apical Periodontitis? 236
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833) 234
Analysis of dysphagia in advanced-stage head-and-neck cancer patients: impact on quality of life and development of a preventive swallowing treatment 230
Clinical outcomes and secondary glaucoma after gamma-knife radiosurgery and Ruthenium-106 brachytherapy for uveal melanoma: a single institution experience 226
A PPAR-gamma agonist protects from radiation-induced intestinal toxicity 225
ADAM phantom to test 4D medical imaging and dose delivery devices 224
Stereotactic vacuum-assisted breast biopsy: Comparison between 11- and 8-gauge needles 222
Stereotactic reirradiation for local failure of brain metastases following previous radiosurgery: Systematic review and meta-analysis 220
Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy? 218
Peroxisome proliferator activated receptor-gamma stimulation for prevention of 5-fluorouracil-induced oral mucositis in mice 215
Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma 214
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 211
SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab 210
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study 210
Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial 209
Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO) 206
Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors 206
Exclusive endocrine therapy or partial breast irradiation for women aged ≥70  years with luminal A-like early stage breast cancer (NCT04134598 – EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measures 206
Influence of age and subtype in outcome of operable liposarcoma 206
AIRO Breast Cancer Group Best Clinical Practice 2022 Update 203
Delta radiomics: a systematic review 203
Gamma Knife Radiosurgery in the management of single and multiple brain metastases 202
Combined use of a transmission detector and an epid-based in vivo dose monitoring system in external beam whole breast irradiation: A study with an anthropomorphic female phantom 202
Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial 202
Cardioprotective Strategy for Patients with Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial 199
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 198
Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature 195
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 195
Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience 193
Soft tissue sarcomas: new opportunity of treatment with PARP inhibitors? 193
Validation of a secondary dose check tool against Monte Carlo and analytical clinical dose calculation algorithms in VMAT 193
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial 192
Radiotherapy in the age of cancer immunology: Current concepts and future developments 190
External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3 randomized trial 190
Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study. 190
Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients 188
Ribociclib plus letrozole and concomitant palliative radiotherapy for metastatic breast cancer 188
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 187
Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility 187
A dosimetric comparison between CyberKnife and tomotherapy treatment plans for single brain metastasis 186
CT assessment of tumor heterogeneity and the potential for the prediction of human papillomavirus status in oropharyngeal squamous cell carcinoma 185
Robotic Stereotactic Retreatment for Biochemical Control in Previously Irradiated Patients Affected by Recurrent Prostate Cancer 185
Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature 184
Stereotactic body radiotherapy with CyberKnife for cardiac malignancies 184
Impact of hormonal status on outcome of ductal carcinoma in situ treated with breast-conserving surgery plus radiotherapy: Long-term experience from two large-institutional series 181
Artificial Intelligence in radiotherapy: state of the art and future directions 180
Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy: Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014) 180
TomoTherapy treatments of multiple brain lesions: an in-phantom accuracy evaluation 180
Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 179
Methodological approach to create an atlas using a commercial auto-contouring software 179
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 178
Re-irradiation as salvage treatment in recurrent glioblastoma: A comprehensive literature review to provide practical answers to frequently asked questions 178
BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management 178
Pleomorphic Xanthoastrocytoma: a single institution retrospective analysis and a review of the literature 177
Conventional and Advanced Magnetic Resonance Imaging Assessment of Non-Enhancing Peritumoral Area in Brain Tumor 176
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 176
Regorafenib in glioblastoma recurrence: A case report 176
Morphological, Functional and Texture Analysis Magnetic Resonance Imaging Features in the Assessment of Radiotherapy-Induced Xerostomia in Oropharyngeal Cancer 175
Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review 175
Endocrine-related adverse events in a large series of cancer patients treated with anti-PD1 therapy 175
A critical review on oligometastatic disease: a radiation oncologist’s perspective 174
Hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: a multi-centre comparative study 173
Hypofractionated Postmastectomy Radiotherapy (HF-PMRT): What did We Learn from COVID-19 Era? 171
Safety of eribulin mesylate and concomitant radiotherapy for metastatic breast cancer: a single-center experience 171
Biomarkers in wound drainage fluids of head and neck squamous cell carcinoma patients receiving neck dissection: A pilot study 171
Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis 170
Magnetic resonance imaging in naso-oropharyngeal carcinoma: role of texture analysis in the assessment of response to radiochemotherapy, a preliminary study 170
PV-0512: Accelerated partial breast irradiation for Luminal-A breast cancer: analysis from a phase 3 trial 170
Outcome and prognostic factors for older patients undergoing radiosurgery for brain metastases 170
Analysis of skin dose distribution for the prediction of severe radiation dermatitis in head and neck squamous cell carcinoma patients treated with concurrent chemo-radiotherapy 169
Nutritional Supplement Based on Zinc, Prebiotics, Probiotics and Vitamins to Prevent Radiation-related Gastrointestinal Disorders 169
Pre-pectoral breast reconstruction: early and long-term safety evaluation of 146 unselected cases of the early pre-pectoral era of a single-institution, including cases with previous breast irradiation and post-mastectomy radiation therapy 168
Thermal Ablation versus SBRT in liver tumours: pros and cons 167
Acupuncture for radiation-induced toxicity in head and neck squamous cell carcinoma: a systematic review based on PICO criteria 167
Open-Face Masks in Radiotherapy: Enhancing Therapeutic Strategies for Head and Neck and Brain Cancer Patients—A Comprehensive Scoping Review 166
Radiomic- and dosiomic-based clustering development for radio-induced neurotoxicity in pediatric medulloblastoma 166
Impact of age on cytotoxic-induced ovarian failure in breast cancer treated with adjuvant chemotherapy and triptorelin 166
Dosimetric Predictors of Acute and Chronic Alopecia in Primary Brain Cancer Patients Treated With Volumetric Modulated Arc Therapy 166
Impact of COVID-19 on workload burden of a complex radiotherapy facility 166
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736) 165
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 164
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy 164
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO 164
Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years 164
Clinical validation of an automatic atlas-based segmentation tool for male pelvis CT images 164
Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719) 161
The impact of patient preference in the treatment algorithm for recurrent/metastatic head and neck squamous cell carcinoma 160
Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 Patients treated with a prospective margin-directed policy 160
Is panoramic radiography really a key examination before chemo-radiotherapy treatment for oropharyngeal cancer? 160
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? 159
Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis 158
Successful Use of Cemiplimab in a Very Elderly Patient With Cutaneous Squamous Cell Carcinoma 157
Totale 19.204
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.699
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021182 0 0 0 0 0 0 0 0 0 0 126 56
2021/2022824 28 46 65 62 24 49 32 79 39 52 121 227
2022/20232.604 174 499 109 112 190 509 357 183 310 14 84 63
2023/20241.611 70 116 181 83 92 224 63 396 36 143 147 60
2024/20259.207 297 865 516 1.453 2.430 1.100 153 516 466 314 435 662
2025/202610.998 1.268 1.599 1.368 1.138 1.322 413 1.429 522 738 790 411 0
Totale 29.414